Impact of molecular markers on treatment selection in advanced colorectal cancer

Eur J Cancer. 2009 Sep:45 Suppl 1:70-8. doi: 10.1016/S0959-8049(09)70018-8.
No abstract available

Publication types

  • Review

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use
  • Antibodies, Monoclonal / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Biomarkers, Tumor / blood*
  • Colorectal Neoplasms / genetics
  • Colorectal Neoplasms / therapy*
  • ErbB Receptors / antagonists & inhibitors
  • Humans
  • Mutation / genetics
  • Neoplastic Cells, Circulating
  • Predictive Value of Tests
  • Prognosis
  • Proto-Oncogene Proteins / metabolism
  • Proto-Oncogene Proteins p21(ras)
  • Randomized Controlled Trials as Topic
  • Receptors, Fc / genetics
  • ras Proteins / metabolism

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Biomarkers, Tumor
  • KRAS protein, human
  • Proto-Oncogene Proteins
  • Receptors, Fc
  • ErbB Receptors
  • Proto-Oncogene Proteins p21(ras)
  • ras Proteins